Journal of Clinical Endocrinology & Metabolism, Vol 66, 580-583, Copyright © 1988 by Endocrine Society

ARTICLES

Resistance to insulin-stimulated-glucose uptake in patients with hypertension

DC Shen, SM Shieh, MM Fuh, DA Wu, YD Chen and GM Reaven
Department of Medicine, Stanford University School of Medicine, California 94304.

Plasma glucose and insulin responses to a glucose challenge and insulin- stimulated glucose uptake were measured in 24 age-, weight-, and sex- matched Chinese men (8 with normal blood pressure, 8 with untreated hypertension, and 8 patients with hypertension treated with thiazide and beta-adrenergic antagonist drugs). Plasma glucose and insulin responses were determined by measuring plasma glucose and insulin concentrations before and at 30-min intervals for 2 h after a 75-g oral glucose dose. Insulin-stimulated glucose uptake was estimated by measuring the steady state plasma glucose (SSPG) and insulin (SSPI) concentrations achieved during the last 60 min of a 180-min continuous infusion of somatostatin, insulin, and glucose (insulin suppression test). Under these conditions endogenous insulin secretion was suppressed, and similar SSPI concentrations were achieved in all men; thus, the differences in the resultant SSPG concentrations allowed direct comparison of insulin's ability to stimulate disposal of an identical glucose load in different individuals. The results indicated that the men with hypertension, whether treated or untreated, had significantly elevated plasma glucose (P less than 0.001) and insulin (P less than 0.001) responses to the oral glucose dose compared to the normal men. Mean (+/- SE) SSPG concentrations were also higher (P less than 0.001) in the men with either untreated hypertension [219 +/- 9 mg/dL (12.2 +/- 0.5 mmol/L)] or treated hypertension [211 +/- 18 mg/dL (11.7 +/- 1.0 mmol/L)] than in the normal men [134 +/- 13 mg/dL (7.4 +/- 0.7 mmol/L)]. Since the mean SSPI concentrations were similar in the 3 groups [approximately 70 microU/mL (502 pmol/L)], insulin was less effective in promoting glucose disposal in both groups with hypertension. These results document the fact that patients with hypertension, whether treated or untreated, are insulin resistant, hyperglycemic, and hyperinsulinemic compared to a well-matched control group.

This article has been cited by other articles:

				C. Schindler Review: The metabolic syndrome as an endocrine disease: is there an effective pharmacotherapeutic strategy optimally targeting the pathogenesis? Therapeutic Advances in Cardiovascular Disease, October 1, 2007; 1(1): 7 - 26. [Abstract] [PDF]

				G. M. Reaven The Individual Components of the Metabolic Syndrome: Is There a Raison d'Etre? J. Am. Coll. Nutr., June 1, 2007; 26(3): 191 - 195. [Full Text] [PDF]

				G. M Reaven The metabolic syndrome: is this diagnosis necessary? Am. J. Clinical Nutrition, June 1, 2006; 83(6): 1237 - 1247. [Abstract] [Full Text] [PDF]

				D. Thornley-Brown, X. Wang, J. T. Wright Jr, O. S. Randall, E. R. Miller, J. P. Lash, J. Gassman, G. Contreras, L. J. Appel, L. Y. Agodoa, et al. Differing effects of antihypertensive drugs on the incidence of diabetes mellitus among patients with hypertensive kidney disease. Arch Intern Med, April 10, 2006; 166(7): 797 - 805. [Abstract] [Full Text] [PDF]

				M. A. Potenza, F. L. Marasciulo, D. M. Chieppa, G. S. Brigiani, G. Formoso, M. J. Quon, and M. Montagnani Insulin resistance in spontaneously hypertensive rats is associated with endothelial dysfunction characterized by imbalance between NO and ET-1 production Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H813 - H822. [Abstract] [Full Text] [PDF]

				K. Sydow, C. E Mondon, and J. P Cooke Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA Vascular Medicine, July 1, 2005; 10(1_suppl): S35 - S43. [Abstract] [PDF]

				K. Sydow, C. E Mondon, and J. P Cooke Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA Vascular Medicine, May 1, 2005; 10(2_suppl): S35 - S43. [Abstract] [PDF]

				C. Morisco, G. Condorelli, V. Trimarco, A. Bellis, C. Marrone, G. Condorelli, J. Sadoshima, and B. Trimarco Akt Mediates the Cross-Talk Between {beta}-Adrenergic and Insulin Receptors in Neonatal Cardiomyocytes Circ. Res., February 4, 2005; 96(2): 180 - 188. [Abstract] [Full Text] [PDF]

				M. F. Saad, M. Rewers, J. Selby, G. Howard, S. Jinagouda, S. Fahmi, D. Zaccaro, R. N. Bergman, P. J. Savage, and S. M. Haffner Insulin Resistance and Hypertension: The Insulin Resistance Atherosclerosis Study Hypertension, June 1, 2004; 43(6): 1324 - 1331. [Abstract] [Full Text] [PDF]

				A. P. Rocchini, J. Q. Yang, and A. Gokee Hypertension and Insulin Resistance Are Not Directly Related in Obese Dogs Hypertension, May 1, 2004; 43(5): 1011 - 1016. [Abstract] [Full Text] [PDF]

				C. Rheaume, P.-H. Waib, N'G. Kouame, A. Nadeau, Y. Lacourciere, D. R. Joanisse, J.-A. Simoneau, and J. Cleroux Effects of Intense and Prolonged Exercise on Insulin Sensitivity and Glycogen Metabolism in Hypertensive Subjects Circulation, November 25, 2003; 108(21): 2653 - 2659. [Abstract] [Full Text] [PDF]

				V. De Leo, A. la Marca, and F. Petraglia Insulin-Lowering Agents in the Management of Polycystic Ovary Syndrome Endocr. Rev., October 1, 2003; 24(5): 633 - 667. [Abstract] [Full Text] [PDF]

				G. M. Reaven Insulin Resistance/Compensatory Hyperinsulinemia, Essential Hypertension, and Cardiovascular Disease J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2399 - 2403. [Full Text] [PDF]

				F. Pont, L. Duvillard, E. Florentin, P. Gambert, and B. Verges Early Kinetic Abnormalities of ApoB-Containing Lipoproteins in Insulin-Resistant Women With Abdominal Obesity Arterioscler. Thromb. Vasc. Biol., October 1, 2002; 22(10): 1726 - 1732. [Abstract] [Full Text] [PDF]

				M. C. Stuhlinger, F. Abbasi, J. W. Chu, C. Lamendola, T. L. McLaughlin, J. P. Cooke, G. M. Reaven, and P. S. Tsao Relationship Between Insulin Resistance and an Endogenous Nitric Oxide Synthase Inhibitor JAMA, March 20, 2002; 287(11): 1420 - 1426. [Abstract] [Full Text] [PDF]

				K. Yasunari, K. Maeda, M. Nakamura, and J. Yoshikawa Oxidative Stress in Leukocytes Is a Possible Link Between Blood Pressure, Blood Glucose, and C-Reacting Protein Hypertension, March 1, 2002; 39(3): 777 - 780. [Abstract] [Full Text] [PDF]

				H. Duplain, R. Burcelin, C. Sartori, S. Cook, M. Egli, M. Lepori, P. Vollenweider, T. Pedrazzini, P. Nicod, B. Thorens, et al. Insulin Resistance, Hyperlipidemia, and Hypertension in Mice Lacking Endothelial Nitric Oxide SynthaseNote Added in Proof Circulation, July 17, 2001; 104(3): 342 - 345. [Abstract] [Full Text] [PDF]

				S. I. McFarlane, M. Banerji, and J. R. Sowers Insulin Resistance and Cardiovascular Disease J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 713 - 718. [Full Text]

				A. Kudoh and A. Matsuki Effects of Angiotensin-Converting Enzyme Inhibitors on Glucose Uptake Hypertension, August 1, 2000; 36(2): 239 - 244. [Abstract] [Full Text] [PDF]

				M. Suzuki, Y. Kimura, M. Tsushima, and Y. Harano Association of Insulin Resistance With Salt Sensitivity and Nocturnal Fall of Blood Pressure Hypertension, April 1, 2000; 35(4): 864 - 868. [Abstract] [Full Text] [PDF]

				O. Melander, L. Groop, and U. L. Hulthen Effect of Salt on Insulin Sensitivity Differs According to Gender and Degree of Salt Sensitivity Hypertension, March 1, 2000; 35(3): 827 - 831. [Abstract] [Full Text] [PDF]

				N.-G. Chen, F. Abbasi, C. Lamendola, T. McLaughlin, J. P. Cooke, P. S. Tsao, and G. M. Reaven Mononuclear Cell Adherence to Cultured Endothelium Is Enhanced by Hypertension and Insulin Resistance in Healthy Nondiabetic Volunteers Circulation, August 31, 1999; 100(9): 940 - 943. [Abstract] [Full Text] [PDF]

				G. Piédrola, E. Novo, J. Serrano-Gotarredona, M. L. de Teresa, and R. García-Robles Evolution of insulin resistance in coronary artery disease patients on four different pharmacological therapies Postgrad. Med. J., January 1, 1999; 75(879): 27 - 31. [Abstract] [Full Text]

				J. Yip, F. S. Facchini, and G. M. Reaven Resistance to Insulin-Mediated Glucose Disposal as a Predictor of Cardiovascular Disease J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2773 - 2776. [Abstract] [Full Text]

				M. Carantoni, F. Abbasi, F. Warmerdam, M. Klebanov, P.-W. Wang, Y.-D. I. Chen, S. Azhar, and G. M. Reaven Relationship Between Insulin Resistance and Partially Oxidized LDL Particles in Healthy, Nondiabetic Volunteers Arterioscler. Thromb. Vasc. Biol., May 1, 1998; 18(5): 762 - 767. [Abstract] [Full Text] [PDF]

				H. G. Preuss, M. Zein, P. MacArthy, D. Dipette, S. Sabnis, and J. Knapka Sugar-Induced Blood Pressure Elevations Over the Lifespan of Three Substrains of Wistar Rats J. Am. Coll. Nutr., February 1, 1998; 17(1): 36 - 37. [Abstract] [Full Text] [PDF]

				U. Scherrer and C. Sartori Insulin as a Vascular and Sympathoexcitatory Hormone : Implications for Blood Pressure Regulation, Insulin Sensitivity, and Cardiovascular Morbidity Circulation, December 2, 1997; 96(11): 4104 - 4113. [Abstract] [Full Text]

				D. Lender, C. Arauz-Pacheco, B. Adams-Huet, and P. Raskin Essential Hypertension Is Associated With Decreased Insulin Clearance and Insulin Resistance Hypertension, January 1, 1997; 29(1): 111 - 114. [Abstract] [Full Text]

				M. Suzuki, K. Shinozaki, A. Kanazawa, Y. Hara, Y. Hattori, M. Tsushima, and Y. Harano Insulin Resistance as an Independent Risk Factor for Carotid Wall Thickening Hypertension, October 1, 1996; 28(4): 593 - 598. [Abstract] [Full Text]

				G.M. Reaven and Y-D.I. Chen Insulin Resistance, Its Consequences, and Coronary Heart Disease : Must We Choose One Culprit? Circulation, May 15, 1996; 93(10): 1780 - 1783. [Full Text]

				L. A. Sechi, C. A. Griffin, G. Giacchetti, L. Zingaro, C. Catena, E. Bartoli, and M. Schambelan Abnormalities of Insulin Receptors in Spontaneously Hypertensive Rats Hypertension, April 1, 1996; 27(4): 955 - 961. [Abstract] [Full Text]

				G. M. Reaven, H. Lithell, and L. Landsberg Hypertension and Associated Metabolic Abnormalities -- The Role of Insulin Resistance and the Sympathoadrenal System N. Engl. J. Med., February 8, 1996; 334(6): 374 - 382. [Full Text] [PDF]

				C. H.R.M. Costa, M. C. Batista, V. A. Moises, N. B. Kohlmann, A. B. Ribeiro, and M.-T. Zanella Serum Insulin Levels, 24-Hour Blood Pressure Profile, and Left Ventricular Mass in Nonobese Hypertensive Patients Hypertension, December 1, 1995; 26(6): 1085 - 1088. [Abstract] [Full Text]

				B. Grunfeld, M. Gimenez, M. Balzaretti, L. Rabinovich, M. Romo, and R. Simsolo Insulin Effect on Renal Sodium Reabsorption in Adolescent Offspring of Essential Hypertensive Parents Hypertension, December 1, 1995; 26(6): 1089 - 1092. [Abstract] [Full Text]

				P. H. McNulty, R. J. Louard, L. I. Deckelbaum, B. L. Zaret, and L. H. Young Hyperinsulinemia Inhibits Myocardial Protein Degradation in Patients With Cardiovascular Disease and Insulin Resistance Circulation, October 15, 1995; 92(8): 2151 - 2156. [Abstract] [Full Text]

				T. Katsuya, M. Horiuchi, Y.-D. I. Chen, G. Koike, R. E. Pratt, V. J. Dzau, and G. M. Reaven Relations Between Deletion Polymorphism of the Angiotensin-Converting Enzyme Gene and Insulin Resistance, Glucose Intolerance, Hyperinsulinemia, and Dyslipidemia Arterioscler. Thromb. Vasc. Biol., June 1, 1995; 15(6): 779 - 782. [Abstract] [Full Text]